Regeneron Pharmaceuticals Inc Balance Sheet Statement

REGN $461.57 12.2 2.7%

05/03/21

Balanced, Large Cap, Style Neutral

Market Cap £35.73bn

Enterprise Value £35.08bn

Revenue £6.14bn

Quality

Value

Momentum

StockRank™

To unlock Regeneron Pharmaceuticals Inc's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Accounts Payable
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Preferred Stock - Non Redeemable, Net
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock - Common
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.